Science Pool
News
Isospec Analytics get support from FIT
The Foundation for Technological Innovation (FIT) is happy to announce new loan Isospec Analytics. Isospec Analytics, specializing in advanced biomolecular analysis, receives a Tech Seed loan of CHF 100’000.
Isospec Analytics get support from FIT
The Foundation for Technological Innovation (FIT) is happy to announce new loan Isospec Analytics. Isospec Analytics, specializing in advanced biomolecular analysis, receives a Tech Seed loan of CHF 100’000.
Isospec Analytics Raises CHF1.9 Million in Pre-Seed Funding to Revolutionize Disease Detection
Isospec Analytics, a Swiss-based startup spun out of EPFL, has secured $1.9 million in pre-seed funding to advance its groundbreaking biomolecular analysis technology. The company's innovative approach promises to identify a significantly larger number of small molecules in blood samples, potentially leading to earlier disease detection and more effective treatments.
Isospec Analytics Raises CHF1.9 Million in Pre-Seed Funding to Revolutionize Disease Detection
Isospec Analytics, a Swiss-based startup spun out of EPFL, has secured $1.9 million in pre-seed funding to advance its groundbreaking biomolecular analysis technology. The company's innovative approach promises to identify a significantly larger number of small molecules in blood samples, potentially leading to earlier disease detection and more effective treatments.
Isospec Analytics Partners with MSVision
MS Vision and Isospec Analytics have formed a partnership to advance molecular analysis by combining cryogenic IR spectroscopy with IMS-MS, aiming to improve the identification of complex molecules and reduce analytical uncertainties.
Isospec Analytics Partners with MSVision
MS Vision and Isospec Analytics have formed a partnership to advance molecular analysis by combining cryogenic IR spectroscopy with IMS-MS, aiming to improve the identification of complex molecules and reduce analytical uncertainties.
Isospec Analytics CSO Prof. Rizzo wins ACS Award
Professor Thomas Rizzo from EPFL is recognized for integrating vibrational spectroscopy with ion mobility and mass spectrometry to innovate bioanalytical science.
Isospec Analytics CSO Prof. Rizzo wins ACS Award
Professor Thomas Rizzo from EPFL is recognized for integrating vibrational spectroscopy with ion mobility and mass spectrometry to innovate bioanalytical science.
Isospec is awarded the Venture Kick Stage III convertible loan
Isospec Analytics won Venture Kick's support for its advanced biomolecular analysis technology, aimed at accelerating drug discovery and development by providing rapid and reliable molecular characterization.
Isospec is awarded the Venture Kick Stage III convertible loan
Isospec Analytics won Venture Kick's support for its advanced biomolecular analysis technology, aimed at accelerating drug discovery and development by providing rapid and reliable molecular characterization.
Case Studies
Example Study 2
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren
Example Study 2
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren
Example Study
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren
Example Study
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren
White Papers
Cryo-IR spectroscopy vs. LC or IMS for glycan identification
Discover how our Cryo-IR technology can transform your glycan analysis. Cryogenic IR spectroscopy inside a mass spectrometer provides an information-rich metric by which to unambiguously identify isomeric glycans. Isospec Analytics introduces groundbreaking Cryo-IR spectroscopy technology for unparalleled glycan identification. Our innovative approach solves the complex puzzle of isomeric structures.
Cryo-IR spectroscopy vs. LC or IMS for glycan identification
Discover how our Cryo-IR technology can transform your glycan analysis. Cryogenic IR spectroscopy inside a mass spectrometer provides an information-rich metric by which to unambiguously identify isomeric glycans. Isospec Analytics introduces groundbreaking Cryo-IR spectroscopy technology for unparalleled glycan identification. Our innovative approach solves the complex puzzle of isomeric structures.
How reliable is MS-MS for de novo molecular structure determination?
In the world of molecular identification, high-resolution mass spectrometry has long been the gold standard. However, a groundbreaking study by van Tetering et al. has shed new light on the limitations of tandem mass spectrometry (MS-MS) for de novo molecular structure determination. This white paper explores the implications of their findings and introduces Isospec Analytics' cutting-edge solution to this critical challenge in molecular analysis.
How reliable is MS-MS for de novo molecular structure determination?
In the world of molecular identification, high-resolution mass spectrometry has long been the gold standard. However, a groundbreaking study by van Tetering et al. has shed new light on the limitations of tandem mass spectrometry (MS-MS) for de novo molecular structure determination. This white paper explores the implications of their findings and introduces Isospec Analytics' cutting-edge solution to this critical challenge in molecular analysis.
Enabling AI for glycoscience
The integration of AI in glycoinformatics requires large, high-quality, glycan datasets to train models, and inconsistent or incorrect annotations can significantly affect the performance of these models. In their review paper entitled: "Glycoinformatics in the Artificial Intelligence Era", Daniel Bojar and Frederique Lisacek explain that the limited use of AI in glycomics to date arises from peculiarities of glyco-data that are notoriously hard to produce and analyze. This white paper explains how Isospec Analytics' technology helps solve this problem.
Enabling AI for glycoscience
The integration of AI in glycoinformatics requires large, high-quality, glycan datasets to train models, and inconsistent or incorrect annotations can significantly affect the performance of these models. In their review paper entitled: "Glycoinformatics in the Artificial Intelligence Era", Daniel Bojar and Frederique Lisacek explain that the limited use of AI in glycomics to date arises from peculiarities of glyco-data that are notoriously hard to produce and analyze. This white paper explains how Isospec Analytics' technology helps solve this problem.
Webinars
Example Webinar
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren
Example Webinar
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren